|
 |
CyclophosphamideThis page contains recent news articles, when available, and an overview of Cyclophosphamide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Cyclophosphamide (when available) Cyclophosphamide is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Alkylating agents are cell cycle-nonspecific. Alkylating agents work by three different mechanisms all of which achieve the same end result - disruption of DNA function and cell death. For management of malignant lymphomas, multiple myeloma,leukemias, mycosis fungoides (advanced disease), neuroblastoma (disseminated disease), adenocarcinoma of the ovary, retinoblastoma and carcinoma of the breast Mechanism Of Action: Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations. News Articles on Cyclophosphamide Ofatumumab, Fludara®, Cytoxan® Regimen Highly Effective for Initial Treatment ... - 05 Jan 2010 Ofatumumab combined with fludarabine and cyclophosphamide (O-FC) shows high activity in patietns with previously untreated chronic lymphocytic leukemia ... Cancer Consultants Leukaemia Treatment Can Be A Shot Away - 05 Jan 2010 Stimulatory Factor 35) followed by three courses of rituximab, a monoclonal antibody, and the chemotherapy drugs fludarabine and cyclophosphamide (FCR). ... Biomed Middle East Risk factors for decreased fertility among male cancer survivors identified - 05 Jan 2010 ...agent dose score or treatment with cyclophosphamide or procarbazine (Matulane, Sigma-Tau) were all associated with decreased HR for siring a pregnancy. HemOncToday Pulse Versus Daily Oral Cyclophosphamide in ANCA-Associated Vasculitis - Jan 4, 2010 The cumulative dose of cyclophosphamide when administered in a pulse dose is half that of the oral regimen. For example, a person who weighs 70 kg receives ... Annals of Internal Medicine No Survival Benefit for 5-FU/Docetaxel After Preoperative Epirubicin ... - Dec 12, 2009 All patients received 4 cycles of epirubicin 150 mg/m 2 plus cyclophosphamide 4000 mg/m 2 every 3 weeks. The women were then randomised to receive either a ... DG News Rodent of the Week: Chemo disrupts birth of new brain cells - Dec 18, 2009 ...use of fluorouracil, a 30.5% reduction following cyclophosphamide, a 22.4% reduction following doxorubicin and a 36% reduction following paclitaxel. ... Los Angeles Times (blog) Anthracycline-Docetaxel Chemo as Effective, but Less Toxic Than Anthracycline ... - Dec 15, 2009 Patients were randomised to receive 4 cycles of a sequential anthracycline-docetaxel regimen comprised of epirubicin 90 mg/m 2 plus cyclophosphamide 600 ... DG News Unequal access to cancer drugs creates 'postal-code lottery' - Jan 4, 2010 Specifically, 84.1 per cent of patients with previously untreated CLL who received rituximab plus chemotherapy [fludarabine and cyclophosphamide] were alive ... Globe and Mail Combination of Herceptin® with Non-anthracycline-based Chemotherapy Appears to ... - Dec 18, 2009 In December 2006 Herceptin was approved by the FDA to be used in combination with Adriamycin® (doxorubicin), cyclophosphamide, and Taxol® (paclitaxel) for ... Cancer Consultants Uveitis a complex disease, but treatable in most cases - Jan 4, 2010 ...“The chemotherapy may be something as simple as once-a-week methotrexate or as complex as episodic intravenous cyclophosphamide or once-monthly Remicade ... OSN SuperSite New study sheds light on apparent toxicity of the brain due to chemotherapy - Dec 25, 2009 The effects of routinely used doses of cyclophosphamide and fluorouracil that do cross into the brain, against paclitaxel and doxorubicin, which do not, ... HealthJockey.com BCIRG 006: Trastuzumab outperforms anthrcycline-based therapy in HER2-positive ... - Dec 15, 2009 ...tumors to either standard doxorubicin and cyclophosphamide followed by docetaxel (ACT) or either doxorubicin/cyclophosphamide/docetaxel with trastuzumab ... HemOncToday Febrile Neutropenia Occurs More Frequently in Real World Setting Than in ... - Dec 11, 2009 ..."We saw febrile neutropenia in 6 of our first 12 patients [who received] the regimen of docetaxel and cyclophosphamide," said Robert Myers, MD, ... DG News T cell-prolymphocytic leukemia detected in a patient of breast cancer at the ... - Jan 4, 2010 She received 6 cycles of chemotherapy with cyclophosphamide, epirubicin, and 5-fluorouracil. This was followed by tamoxifen 20mg per day for five years. ... 7thSpace Interactive (press release) Immune-Boosting Drugs Could Enhance Cancer Treatment - Dec 14, 2009 They found that both ox and gem were effective, whilst cyclophosphamide did not stimulate the immune cells. In lab based experiments conducted with human ... Science Daily (press release) Role of chemotherapy in the management of primary rectal lymphoma: a case ... - Dec 22, 2009 This patient was managed successfully with 8 treatment cycles of Cyclophosphamide 750 mg/m2 at day 1 of each cycle, Doxorubicin (50 mg/m2 in the first 4 ... 7thSpace Interactive (press release) Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients - Dec 11, 2009 The chemo regimen used is called CAF, for "cyclophosphamide, Adriamycin and 5-fluorouracil." In all, after accounting for study dropouts, ... U.S. News & World Report Addition Of Thalidomide To Induction Therapy Increases Response Rates In ... - Dec 29, 2009 The younger patients, median age 59 years, were randomized to receive one of two induction therapies – either cyclophosphamide (Cytoxan), thalidomide, ... The Myeloma Beacon Ovarian cancer: A silent women's killer - Dec 27, 2009 Drug combinations were CMF-cyclophosphamide, methotrexate, 5-fluorouracil, CMFP-CMF plus prednisone, and CAF-cyclophosphamide, adriamycin, 5-fluorouracil), ... The Guardian - Nigeria Addition of rituximab improves OS in chronic lymphocytic leukemia - Dec 28, 2009 ...that rituximab (Rituxan) plus fludarabine and cyclophosphamide (FC) chemotherapy improved overall survival in patients with previously untreated chronic ... Cancer Network Survivin(g) Adult T-cell Leukemia/Lymphoma - Dec 17, 2009 ...[6] As summarized, the investigators randomized patients to the eight-drug LSG15 regimen (VCAP-AMP-VECP, consisting of vincristine, cyclophosphamide, ... Cancer Network Treatment Updates - Dec 23, 2009 ...—MW Combining Fludara (fludarabine), Cytoxan (cyclophosphamide), and Rituxan (rituximab) was safer and produced a higher response than pairing Campath ... Curetoday.com (press release) Improved survival in advanced stage mantle cell lymphoma - Dec 11, 2009 To strengthen earlier MCL treatment approaches, regimens from the 1970s that used chlorambucil and prednisone or cyclophosphamide, vincristine, ... American Journal of Hemotology and Oncology Sprycel® and Chemotherapy Effective for Ph+ ALL - Dec 10, 2009 Researchers from the MD Anderson Cancer Center have reported that a regimen of Sprycel® (dasatinib) and Hypercvad® (cyclophosphamide, vincristine, ... Cancer Consultants New FDA approved breast cancer genetic test improves patient treatment and ... - Dec 23, 2009 ...or a combination of chemotherapeutic drugs such as nitrosoureas (cyclophosphamide) with doxorubicin, administering estrogen and progesterone receptor ... Examiner.com HER2-like And Basal-Like Genotype Breast Cancer Are More Likely To Respond To ... - Dec 26, 2009 These regimens include docetaxel, doxorubicin, cyclophosphamide (TAC); doxurubicin, cyclophosphamide, and nab--paclitaxel; and carboplatin with or without ... Medical News Today Genentech and Biogen Idec Present Follow Up Trial Results at ASH Annual Meeting - Dec 9, 2009 ..."These data showed that at three years of follow up, more patients who received Rituxan with fludarabine and cyclophosphamide chemotherapy were alive ... Trading Markets (press release) Tandem Autologous-Allogeneic Stem Cell Transplants Highly Effective for ... - Dec 23, 2009 Researchers from the MD Anderson Cancer Center have previously reported that reduced-intensity allogeneic SCT, using a fludarabine, cyclophosphamide ... Cancer Consultants Big Pharma Adopting Orphan Drug Strategy - Dec 14, 2009 Then in February 2006, it was sanctioned for use in combination with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) or other ... Genetic Engineering News (press release) Post-treatment pain remains clinically significant in breast cancer patients - Dec 28, 2009 On the basis of their estrogen-receptor status and histopathology, patients underwent antiestrogen treatment and standard chemotherapy with cyclophosphamide ... Cancer Network Rituxan Equally Effective as Standard Therapy for Treating Vasculitis - Dec 21, 2009 According to background information provided in the article, prior to the use of cyclophosphamide treatment, 70% of patients who were diagnosed with severe ... Oncology Nursing News Oncotype Dx® Predicts Chemotherapy Benefit in Node-positive Breast Cancer - Dec 15, 2009 One-hundred forty-eight patients received adjuvant therapy with tamoxifen [Nolvadex®] alone (T), and 219 received tamoxifen plus cyclophosphamide, ... Cancer Consultants “Miniâ€? stem cell transplantation – hope for sickle cell disease - Dec 17, 2009 ...studies on immune cells gathered from patients in the study and looking at a combination of rapamycin with a well known cancer drug cyclophosphamide. ... Biomed Middle East Pemphigus: Recent Research - Dec 29, 2009 Additional drug treatments include azathioprine, cyclophosphamide, methotrexate, mycophenolate mofetil, and cyclosporine. As with other autoimmune ... EmpowHer (blog) Revlimid® Delays Progression of Multiple Myeloma After Stem Cell Transplantation - Dec 21, 2009 Peripheral blood stem cells were harvested after Cytoxan® (cyclophosphamide) and Neupogen® (filgrastim). Four courses of consolidation Revlimid was given ... Cancer Consultants Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case ... - Dec 29, 2009 The incriminated drug was discontinued and urgent life saving therapy in the form of broad spectrum antibiotic, immunosuppression with cyclophosphamide, ... 7thSpace Interactive (press release) How Much To Extend Life? Allos Therapeutics Says $30000 per Month - Dec 14, 2009 According to the medical literature, there is no cure and a significant number of first-line CHOP — cyclophosphamide, doxorubicin, vincristine and ... BNET Roche Says Rituxan Showed Improved Overall Survival In Previously Untreated ... - Dec 11, 2009 ...plus fludarabine and cyclophosphamide, or FC, were alive after more than three years of follow up compared to 79.0% of patients who received FC alone. ... RTT News Novel Therapeutic Agents May Improve Kidney Impairment In Newly Diagnosed ... - Dec 26, 2009 Patients in group B received treatment with thalidomide (Thalomid) or Revlimid (lenalidomide) with high-dose dexamethasone and/or cyclophosphamide or ... The Myeloma Beacon Effects of estrogens and bladder inflammation on mitogen-activated protein ... - Dec 28, 2009 Although ovariectomy increased the level of phosphorylated ERK1 (vs. total ERK1), cyclophosphamide-induced lower urinary tract inflammation did not cause a ... 7thSpace Interactive (press release) The heart risks posed by battle against cancer - Dec 14, 2009 The drug 5-Fluorouracil has been linked to a reduced supply of oxygen to heart muscle, while cyclophosphamide may cause mild valve problems. ... Irish Times Cisplatin Linked to Complete Response in Breast Cancer And, geriatric ... - Dec 18, 2009 The rates ranged from 7 percent in women treated with cyclophosphamide, methotrexate, and fluorouracil to 83 percent in women treated with cisplatin. ... ModernMedicine SABCS: No Need for Anthracycline with Trastuzumab - Dec 12, 2009 3222 HER2-positive breast cancer patients, compared standard anthracycline-based chemotherapy -- doxorubicin (Adriamycin), cyclophosphamide (Cytoxan), ... MedPage Today Immutep Announces Final Results In Phase I/II Chemoimmunotherapy Trial In ... - Jan 4, 2010 This mechanism of therapeutic synergy has been shown with cyclophosphamide, doxorubicin, or paclitaxel when given with dendritic cell–based vaccines. ... PipelineReview.com (press release) Wegener's granulomatosis presenting as an abdominal aortic aneurysm: a case report - Dec 18, 2009 He was treated with oral steroids and cyclophosphamide. His graft leaked and had to be replaced with a synthetic graft. Two months after his re-operation, ... 7thSpace Interactive (press release) Zevalin® (Ibritumomab Tiuxetan) Demonstrated Activity in Several ... - Dec 11, 2009 ...or with fludarabine, cyclophosphamide and rituximab (Blood 2008:111:5530) in candidates for NST (relapsed chemosensitive or refractory FL and MCL, ... Benzinga Serum levels of autoantibodies against C-reactive protein correlate with renal ... - Dec 11, 2009 Treatment with corticosteroids combined with cyclophosphamide, mycophenolate mofetil or rituximab was started after baseline kidney biopsy. ... 7thSpace Interactive (press release) Trastuzumab plus chemotherapy for maximum benefit - Dec 18, 2009 All patients enrolled in this phase III trial were receiving standard chemotherapy of doxorubicin and cyclophosphamide followed by paclitaxel. ... ecancermedicalscience US Oncology Research Network Participates in Seven Oral Clinical Studies ... - Dec 17, 2009 12, titled, "Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC[rarr]T) with doxorubicin and cyclophosphamide ... PR-CANADA.net (press release) Miracle drug boosts William's cancer recovery - Dec 16, 2009 Then in January he was given two chemotherapy drugs to target the spleen - Fludarabine and Cyclophosphamide - and he was on these until September,â€? said ... Midulster Today Living with Lupus - 14 Nov 2009 Pregnancies must be carefully monitored and certain medications avoided (such as cyclophosphamide, methotrexate, cyclosporine and mycophenolate) that would ... Sunday Times.lk Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R ... - Nov 12, 2009 Significant improvement in recurrence-free survival (RFS) when capecitabine (X) is integrated into docetaxel (T) 5-FU + epirubicin + cyclophosphamide (CEF) ... PR Newswire (press release) Breast Cancer Regimen Effective But Toxic - Nov 10, 2009 Taxanes and cyclophosphamide increased tumor concentrations of thymidine phosphorylase in preclinical models, suggesting that administration with ... MedPage Today Rituximab May Be Alternative to Cyclophosphamide for Antineutrophil ... - Oct 20, 2009 PHILADELPHIA -- October 20, 2009 -- Rituximab may provide an alternative to cyclophosphamide therapy in patients with antineutrophil ... DG News Another NICE green light for MabThera on the NHS - Nov 12, 2009 ...the drug in combination with the chemotherapy regimen fludarabine and cyclophosphamide as an option for relapsed/refractory forms of the cancer. ... Pharma Times Different therapy for vasculitis reduces devastating side effect - Oct 30, 2009 In the case of cyclophosphamide, the treatment for ANCA-associated vasculitis, the side effects can sometimes be worse than the disease itself. ... Johns Hopkins News-Letter Cerebral involvement in a patient with Goodpasture's disease due to shortened ... - Nov 13, 2009 In addition, cyclophosphamide pulse therapy was given on day 13. Encephalopathy and MRI lesions disappeared during this therapy, and antiglomerular basement ... 7thSpace Interactive (press release) What is Goodpasture Syndrome? - Oct 18, 2009 Steroids and cyclophosphamide suppress the body's immune system. This means that the person is more at risk for infections. # Cyclophosphamide can sometimes ... 24 Medica What is Histiocytosis? - Oct 20, 2009 Other medications, such as cyclophosphamide, may also be tried. However, no therapy clearly helps this disease. Sometimes radiation therapy is used to treat ... 24 Medica FAQ: Psoriatic Arthritis - Nov 9, 2009 Other immunosuppressant medications include azathioprine and cyclophosphamide. - disease-modifiying medications, such as sulfasalazine and ... 24 Medica Risk of LVF Decline in Breast Cancer Patients Decreases With Left-Side ... - Nov 9, 2009 The study looked at 3505 women with HER2-positive breast cancer who were randomised to received doxorubicin, paclitaxel, and cyclophosphamide, ... DG News Report Highlights Cancer Advances - Nov 9, 2009 Women randomized to the single agent had a twofold increase in the risk of relapse and death compared with women who received cyclophosphamide, ... MedPage Today ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress - Nov 11, 2009 It is expected to overcome the resistance seen with ifosfamide and cyclophosphamide, two of the most commonly used alkylating drugs used to treat certain ... Business Wire (press release) 'Doxo' Going to Like This One: Ziopharm's Phase II Wins Big - Nov 6, 2009 Ifosfamide and cyclophosphamide are two of the most commonly used alkylating drugs to treat certain cancers, but patients often develop resistance. ... BioWorld Online Is a raspy voice a common chemo side effect? - Nov 4, 2009 This regimen involves five anti-cancer drugs: rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone. These are potent drugs given over a ... CNN Drug Could Provide First Treatment For Scleroderma - Oct 18, 2009 Several years ago, a small study provided some evidence that a chemotherapy drug called cyclophosphamide may help scleroderma patients, but the benefit was ... Science Daily (press release) Genmab to Sell Manufacturing Facility and Cut 300 Jobs - Nov 5, 2009 During August Genmab announced positive Phase II results of Arzerra as a front-line treatment in combination with cyclophosphamide, doxorubicin, vincristine ... Genetic Engineering News (press release) Millennium Initiates Phase II Trial for Diffuse Large B-Cell Lymphoma - Oct 21, 2009 ...(Business Wire)-- Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, ... Reuters Updated NCCN Guidelines for Breast Cancer Discourages Prophylactic Mastectomy ... - Oct 28, 2009 The NCCN Guidelines now include FEC [fluorouracil (Adrucil(R), Pfizer Inc.) / epirubicin (Ellence(R), Pfizer Inc.) / cyclophosphamide (Cytoxan(R), ... Reuters Pixantrone Produces High Rates of Complete Remission in Multiple Relapsed and ... - Oct 21, 2009 II trial in patients treated with CPOP regimen (cyclophosphamide, pixantrone, vincristine, prednisone) for patients that failed CHOP (cycophosphamide, ... Reuters Comparing notes: UK's cancer leaders discuss the latest advances - Oct 28, 2009 Lenalidomide, cyclophosphamide and dexamethasone produce an overall response rate of 78% in patients with newly diagnosed myeloma. ... Pharmafocus Autoimmune hepatitis - Nov 3, 2009 Other alternatives include cyclophosphamide, methotrexate, cyclosporin A and tacrolimus. All of these agents have been only been tested in small trials. ... OnMedica Blopress Plus - Nov 2, 2009 Vitamin D, beta-blockers, diazoxide, anticholinergic agents (eg atropine, beperiden), amantadine, cytotoxic drugs (eg cyclophosphamide, methotrexate), ... Irish Medical Times Patient with neuromyelitis optica and inflammatory demyelinating lesions ... - Oct 23, 2009 Since there was no significant clinical improvement, we decided to use cyclophosphamide therapy, which resulted in good clinical improvement and gradual ... 7thSpace Interactive (press release) COMUNICADO: Estudio en The Lancet Oncology muestra que la capecitabina reduce ... - Nov 11, 2009 Significant improvement in recurrence-free survival (RFS) when capecitabine (X) is integrated into docetaxel (T) 5-FU + epirubicin + cyclophosphamide (CEF) ... Europa Press MMF superior to IV cyclophosphamide in lupus nephritis - Nov 25, 2005 Boston, MA - A randomized open-label trial comparing induction therapy with mycophenolate mofetil (MMF; CellCept, Aspreva/Roche) and the current standard of ... Medscape Balancing efficacy and cancer risk of cyclophosphamide for patients... - Jan 21, 2008 Faurschou M et al. (2008) Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. ... Nature.com Can methotrexate replace cyclophosphamide in the treatment of a... - Oct 14, 2005 ...de Groot K et al. (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic ... Nature.com Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic … - Oct 23, 2008 Although the combination of fludarabine, cyclophosphamide and rituximab is an effective treatment for chronic lymphocytic leukemia, it might be too toxic ... Nature.com Cyclophosphamide plus steroids for membranous nephropathy with … - Jun 15, 2007 Jha V et al. (2007) A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous ... Nature.com Cancer, Premature Menopause Linked - Jul 4, 2006 ...percent _ for survivors who had received radiation to the lower abdomen plus so-called"alkylating"chemotherapy agents, drugs such as cyclophosphamide. FOXNews … to intermediate-dose cyclophosphamide and lenograstim for stem cell - May 28, 2007 2 One patient who previously failed mobilization with cyclophosphamide and G-CSF alone successfully underwent blood stem cell harvesting and high-dose ... Nature.com Deadly problems halt breast cancer study - May 17, 2005 Taxotere or the more conventional combination of doxorubicin plus cyclophosphamide. But they stopped the study after a little over three years, in 2003. ... msnbc.com Fludarabine, cyclophosphamide and horse antithymocyte globulin … - Mar 6, 2006 Correspondence: Professor R Kumar, Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. ... Nature.com … sclerosis: is treatment with cyclophosphamide more effective than ... - Mar 5, 2007 Research in the treatment of idiopathic pulmonary fibrosis has indicated that cyclophosphamide might be a novel treatment for lung involvement in systemic ... Nature.com … and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC - Aug 28, 2008 For standard arms, the dose of anthracycline and cyclophosphamide were reduced by 20% and G-CSF administered according to American Society of Clinical ... Nature.com Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved … - Feb 27, 2006 Correspondence: Dr M Mabed, Hematology and Medical Oncology Unit, Faculty of Medicine, Mansoura University, Mansoura 35111, Egypt. ... Nature.com Intensified dose of cyclophosphamide with G-CSF support versus … - May 23, 2007 ICON3 trial results have suggested that CAP and carboplatin–taxol regimens as first-line treatment of advanced ovarian cancer (AOC) yield similar survival. ... Nature.com Drugs reduce breast cancer deaths - Jun 2, 2005 It is a combination of standard drugs, adriamycin and cyclophosphamide, and the newer drug docetaxel (Taxotere). The Breast Cancer International Research ... BBC News New approach promising against multiple sclerosis - Jun 9, 2008 Their small study showed that treatment with high doses of cyclophosphamide, a generic cancer drug that has been around for half a century, cut the level of ... Reuters Cyclophosphamide followed by fludarabine for untreated chronic … - Sep 29, 2005 Correspondence: Dr MA Hussein, Southwest Oncology Group (S9706), Operations Office, 14980 Omicron Drive, San Antonio, Texas 78245-3217, USA. ... Nature.com Drug Shows Limited Promise Against Perilous Skin Disease - Jun 22, 2006 The drug is cyclophosphamide, or Cytoxan, which has been used for years to treat cancer and some autoimmune disorders. In the study, it slowed skin ... New York Times Lupus drug may cause sperm damage - Jun 29, 2007 Their analysis showed men with lupus who had more treatments of intravenous cyclophosphamide (also known as Cytoxan) were much more likely to have permanent ... æ–°å?Žç½‘ Mycophenolate May Be Better Than Cyclophosphamide in Inducing... - Nov 23, 2005 Nov. 23, 2005 — Mycophenolate mofetil is more effective than cyclophosphamide in inducing remission for lupus nephritis, according to the results of a ... Medscape Cyclophosphamide (Systemic). - Feb 1, 2006 Cyclophosphamide (sye-kloe-FOSS-fa-mide ) belongs to the group of medicines called alkylating agents. It is used to treat cancer of the ovaries, breast, ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com What Are The Drugs, Timetable And Possible Side Effects Expected With... - Oct 19, 2007 Answer: TC is docetaxel and cyclophosphamide. ... These two drugs -- docetaxel and cyclophosphamide -- are given once every three weeks, four times in total ... ABC News macroglobulinemia, fludarabine, cyclophosphamide - Mar 25, 2005 Waldenström's macroglobulinemia (WM), or macroglobulinemic lymphoma, is a generalized chronic lymphoproliferative disorder characterized by the production ... Nature.com … Effective Than Doxorubicin-Cyclophosphamide: Presented at SABCS - Dec 15, 2008 SAN ANTONIO, Tex -- December 15, 2008 -- The combination of doxorubicin and docetaxel is no more effective than doxorubicin and cyclophosphamide in the ... DG News Doxorubicin/Cyclophosphamide Followed by Paclitaxel Inferior to … - Dec 18, 2006 By Emma Hitt, PhD. SAN ANTONIO, TX -- December 18, 2006 -- In women with operable breast cancer, doxorubicin/cyclophosphamide followed by paclitaxel (AC/T) ... DG News REFILE-Aspreva lupus drug fails to meet main goal - Jun 27, 2007 VX) for the drug, said CellCept was not superior to intravenous cyclophosphamide, the current standard of care for lupus nephritis, in inducing treatment ... Reuters Cyclophosphamide for rheumatoid arthritis - Aug 18, 2008 Cyclophosphamide is an immunosuppressive medicine, which means that it decreases the effects of your body's immune system. By interrupting the immune ... MSN Health & Fitness Aspreva Pulls Plans for CellCept - Sep 10, 2007 ...meet its primary objective of demonstrating superiority of CellCept compared to intravenous cyclophosphamide (IVC) for inducing treatment response. ... TheStreet.com - TheStreet.com (subscription) Cancer drug slows scleroderma lung failure - study - Jun 22, 2006 Of the 158 patients who took the chemotherapy drug cyclophosphamide, ... There is concern that cyclophosphamide, which is available in generic form, ... Malaysia Star Taxotere/Cyclophosphamide Offers Greater Disease-Free Survival for … - Dec 13, 2005 By Ed Susman. SAN ANTONIO, TX -- December 13, 2005 -- The combination of docetaxel (Taxotere) and cyclophosphamide should replace doxorubicin ... DG News Ewing's Family of Tumors - Dec 5, 2008 Most protocols use cyclophosphamide as well. ... The mode of administration and dose intensity of cyclophosphamide within courses differs markedly between ... WebMD Biogen starts leukemia trial - Feb 7, 2007 Biogen Idec said its trial will compare treatment with lumiliximab in combination with fludaribine, cyclophosphamide, and rituximab, an emerging standard of ... Boston Globe Researchers discover how cyclophosphamide chemotherapy drug helps … - Aug 31, 2006 Researchers here have discovered how a specific chemotherapy drug helps a cancer-killing virus. The virus is being tested in animals for the treatment of ... News-Medical.net … In Patients Receiving Cyclophosphamide To Treat Glomerulonephritis - Dec 24, 2008 UroToday.com - Cyclophosphamide is the immunosuppressant drug of choice for ... Gonadal failure after immunosuppressive therapy with cyclophosphamide is a ... Medical News Today - Medical News Today (press release) Cyclophosphamide Appears to Prolong Immunosuppression After … - Oct 4, 2005 By Bruce Sylvester. THESSALONIKI, GREECE -- October 4, 2005 -- Cyclophosphamide low-dose therapy appears feasible and safe when used to extend the ... DG News Differences emerge in chemo success - Dec 17, 2006 The Canadian-developed regime is called CEF, short for cyclophosphamide, epirubicin and fluorouracil. It is commonly used in this country. ... Globe and Mail … for Fertility Preservation in Patients Receiving Cyclophosphamide... - Dec 17, 2008 Gonadal failure after immunosuppressive therapy with cyclophosphamide is a ... Prepubertal patients who receive large doses of cyclophosphamide seem to ... UroToday International Journal Drug Combo Effective Against Leukemia - Jul 19, 2007 Together, the studies show that fludarabine plus cyclophosphamide should be ... Treatment with fludarabine plus cyclophosphamide was associated with a ... WebMD High-Dosage of Epirubicin and Cyclophosphamide may cause AML - Jul 14, 2005 Adjuvant chemotherapy with epirubicin and cyclophosphamide for early breast cancer patients increased the risk of Acute myeloid leukemia or Myelodysplastic ... MedIndia When should patients with ANCA-associated vasculitis be switched from... - Dec 3, 2006 Since the introduction of daily oral cyclophosphamide and corticosteroids ... Concerns about the toxicity of cyclophosphamide in patients with AASV have ... Nature.com Millennium expands Velcade tests - Aug 15, 2007 ...dexamethasone, and cyclophosphamide in the front-line multiple myeloma setting, Millennium said; multiple myeloma is a form of blood cancer. ... Boston Globe … Adjuvant Regimen TC (Docetaxel and Cyclophosphamide) Is Superior... - Dec 11, 2005 11 /PRNewswire/ -- The final analysis of an AC/TC adjuvant chemotherapy trial showed that TC (Docetaxel/Cyclophosphamide, 4 cycles) produced a superior ... Free with registration - PR Newswire - AccessMyLibrary.com Genentech touts test of Rituxan plus chemo vs. leukemia - Oct 7, 2008 Researchers said the drug, combined with fludarabine and cyclophosphamide chemotherapy, improved patient survival compared with chemotherapy alone. ... Bizjournals.com Metronomic Cyclophosphamide Adds Value to Neoadjuvant Hormonal … - Oct 1, 2006 By William B. Ershler, MD, Editor, INOVA Fairfax Hospital Cancer Center, Fairfax, VA; Director, Institute for Advanced Studies in Aging, Washington, DC. ... Pay-Per-View - Clinical Oncology Report - Factiva, from Dow Jones Cancer Drug Shows Promise Against Scleroderma . - May 25, 2005 On average, Tashkin said, all of the patients showed progression of lung scarring, but those receiving cyclophosphamide progressed more slowly. ... Pittsburgh Post-Gazette - Google News Archive Discussion of the 2007 British Society for Rheumatology guidelines... - Jan 22, 2008 The guidelines focus on the use of cyclophosphamide, in particular its indications, ... In our experience, by limiting exposure to cyclophosphamide, ... Nature.com Short-Term Exposure to Cyclophosphamide Reduces Long-Term Brain … - Oct 22, 2007 By Chris Berrie. PRAGUE, CZECH REPUBLIC -- October 22, 2007 -- Short-term exposure to the potent immunosuppressive effects of cyclophosphamide can prevent ... DG News … Combination Comparable With Standard Doxorubicin-Cyclophosphamide … - Dec 13, 2005 ...[Presentation title: Preoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADOC) as ... DG News Taxotere / Cyclophosphamide Improves Disease-Free Survival - Feb 17, 2006 If you have early-stage breast cancer and you are deciding on chemotherapy treatment with your doctor, you should ask about the Taxotere/cyclophosphamide ... Breastcancer.org Fludarabine/Cyclophosphamide/Rituximab Successful Against CLL - Dec 22, 2008 NEW YORK DEC 22, 2008 (Reuters Health) - Sequential therapy using fludarabine, high-dose cyclophosphamide and rituximab produces high-quality responses in ... Cancerpage.com A CLOSER LOOK RESEARCH FINDINGS - Feb 6, 2006 Lupus is commonly treated with intravenous cyclophosphamide, an anti-cancer ... However, cyclophosphamide does not cure the disease and is associated with ... $2.95 - Milwaukee Journal Sentinel - NewsBank BRIEFLY; New therapy eases lupus side effects - Nov 28, 2005 ...compared with just 6% of those who received the older treatment, cyclophosphamide. The CellCept patients also had fewer side effects. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver … of Research on Combination Reovirus and Cyclophosphamide … - Jul 1, 2008 The paper, entitled "Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus" appears online ... ITNews New Combination Treatment For Chronic Lymphocytic Leukemia … - Jul 25, 2007 ...“Fludarabine plus cyclophosphamide should now become the standard treatment for chronic lymphocytic leukemia and the basis for new protocols that ... sciencedaily.com Cancer therapy found to help scleroderma Treatment among first to … - May 30, 2005 Patients taking cyclophosphamide had a significant improvement in lung ... The next step, Tashkin said, will be to combine cyclophosphamide with other drugs ... Milwaukee Journal Sentinel - Google News Archive Cyclophosphamide protects against myocardial ischemia/reperfusion … - Jan 4, 2008 ...* Address for reprints: Yuan-gang Qiu, MD, Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University, ... The Journal of Thoracic and Cardiovascul... Liposomal Doxorubicin Plus Cyclophosphamide Shows Promise in … - Feb 3, 2006 By Jill Stein. PARIS, FRANCE -- February 3, 2006 -- The combination of liposome-encapsulated doxorubicin (Myocet) plus cyclophosphamide has demonstrated ... DG News Study finds drug works against scleroderma lung disease - May 24, 2005 Although previous studies have suggested that cyclophosphamide may benefit people ... Cyclophosphamide is sometimes used as a treatment for leukemia, ... Medical News Today - Medical News Today (press release) Cyclophosphamide May Slow Decline of Lung Function in Scleroderma - May 31, 2005 May 31, 2005 (San Diego) — Cyclophosphamide (Cytoxan) has shown effectiveness in scleroderma lung disease, according to a multicenter study presented here ... Medscape How It Works - Aug 31, 2007 Cyclophosphamide is an alkylating agent and is related to mustard gas. ... Cyclophosphamide is available as an intravenous (IV) medicine and as tablets for ... WebMD Life-threatening Complications From Doxorubicin-Docetaxel … - Nov 2, 2005 Following the addition of prophylactic G-CSF in the GEICAM trial, the rate of febrile neutropenia associated with the docetaxel-doxorubicin-cyclophosphamide ... Journal of American Medical Association - Journal of American Medical Association... Rituxan in Combination with Chemotherapy Improves Progression-Free … - Dec 6, 2008 Immunotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) Versus ... Both studies evaluated Rituxan plus fludarabine and cyclophosphamide ... International Business Times GARDEN STATE BRIEFS - Dec 30, 2005 The application proposes the use of Genasense plus fludarabine and cyclophosphamide as treatment for patients with relapsed or refractory chronic ... Pay-Per-View - Star-Ledger - Factiva, from Dow Jones High-Dose Cyclophosphamide Promising for Refractory MS - Dec 1, 2006 Characterized by a triad of symptoms including inflammation, demyelination, and gliosis, multiple sclerosis (MS) affects approximately 1.1 million persons ... Psychiatric Times Interstitial Lung Disease and Connective Tissue Disease - Jan 9, 2007 Therapies for this entity have not been well studied except in the case of the recent scleroderma treatment trial of cyclophosphamide. ... Medscape … Rituximab to Fludarabine and Cyclophosphamide Improves Outcomes in... - Dec 7, 2008 By Emma Hitt, PhD. SAN FRANCISCO -- December 7, 2008 -- Fludarabine, cyclophosphamide, and rituximab (FCR) chemoimmunotherapy improves response rates and ... DG News MMF an alternative to cyclophosphamide for severe lupus nephritis - Jul 7, 2005 Chicago, IL - Evidence continues to accumulate that mycophenolate mofetil (MMF) (CellCept, Roche Pharmaceuticals) is an alternative to cyclophosphamide in ... Medscape … Of Childhood Cancers Treated With Cyclophosphamide More Likely To ... - May 15, 2008 Survivors of childhood cancers treated with the chemotherapy drug cyclophosphamide were five times more likely to develop bladder cancer later in life than ... Medical News Today - Medical News Today (press release) New therapy gives hope to breast cancer patients - Jun 11, 2006 After three to six weeks of rest, patients get two more cancer drugs, doxorubicin and cyclophosphamide, followed by radiation. $2.95 - Kansas City Star - NewsBank … Of Continuous Low-Dose Oral Cyclophosphamide And Celecoxib For … - Nov 22, 2006 UroToday.com - Traditional chemotherapeutic regimens given at high doses in an intermittent fashion have demonstrated little to no activity in the treatment ... Medical News Today - Medical News Today (press release) Clinical Trial Focuses on New Drug for Solid Cancer Tumors and NHL - Dec 11, 2008 Cyclophosphamide kills cancer cells by damaging the materials that makes up one's ... ABT-888 may prevent such repair so that cyclophosphamide can kill more ... newswise.com Hepatotoxicity after low-dose cyclophosphamide therapy.(Letter to the... - Dec 1, 2006 To the Editor: Hepatotoxicity during high-dose cyclophosphamide (CYC) therapy has been reported, (1,2) but hepatitis due to low-dose CYC treatment has ... $4.95 - Southern Medical Journal - ECNext Oncolytics Biotech, Inc. announces publication of research - Jan 8, 2008 The paper, entitled 'Cyclophosphamide Facilitates Antitumour Efficacy against Subcutaneous Tumours following Intravenous Delivery of Reovirus' appears ... Science Centric … Activity and Disability With High-Dose Cyclophosphamide in Patients... - Jun 9, 2008 Intervention Patients received 50 mg/kg/d of cyclophosphamide intravenously ... This immunoablative regimen of cyclophosphamide for patients with aggressive ... Archives of Neurology … recurrence rate lowered by biweekly doxorubicin/cyclophosphamide... - Jun 14, 2006 2006 JUN 14 - (NewsRx.com) -- Node-positive breast cancer recurrence and death rates were lowered with doxorubicin/cyclophosphamide plus paclitaxel when ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Cyclophosphamide improves scleroderma but benefits wane - Dec 31, 2007 NEW YORK (Reuters Health) - One year of treatment with cyclophosphamide results in significant improvements in lung function, skin scores, dyspnea, ... news Stories Cyclophosphamide Aids Fludarabine Against Leukemia - Feb 17, 2006 NEW YORK FEB 17, 2006 (Reuters Health) - Adding cyclophosphamide to fludarabine results in greater response rates and longer treatment- and progression-free ... Cancerpage.com Low dose cyclophosphamide rescues myocardial function from ischemia- … - Jan 28, 2008 ...* Corresponding author. Address: Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, ... European Journal of Cardio-Thoracic... High-Dose Cyclophosphamide Achieves Rapid Clinical Improvements in … - Apr 6, 2006 By Claire Sowerbutt. SAN DIEGO, CA -- April 6, 2006 -- Preliminary data from a study utilising 50 mg/kg/day of cyclophosphamide (HiCy) for 4 consecutive ... DG News Monoclonal gammopathy and glomerulopathy associated with chronic … - May 30, 2008 Management Treatment with prednisone and cyclophosphamide did not ... The patient did not tolerate high-dose cyclophosphamide and was started on rituximab. ... Nature.com Doxorubicin plus docetaxel as effective as standard therapy for early... - May 19, 2005 Doxorubicin/docetaxel was associated with more severe side effects than doxorubicin/cyclophosphamide, however, with 19% of women experiencing febrile ... Virtual Medical Centre - The Virtual Medical Centre Oncolytics Cleared for UK Reolysin Trial - Oct 26, 2007 The primary objectives of the trial include determining the minimum effective immunomodulatory dose of cyclophosphamide to obtain successful immune ... RedOrbit Genentech and Biogen Idec claim positive rituxan data - Oct 9, 2008 When used in combination with fludarabine and cyclophosphamide chemotherapy, rituxan achieved its primary endpoint of improving progression-free survival ... Hays Pharma Cladribine Effective in Combination Therapy for Treating Chronic … - Dec 9, 2008 The randomised trial compared the efficacy of 2 purine analogues, cladribine and fludarabine, in combination with cyclophosphamide for the treatment of CLL. ... DG News ZIOPHARM Presents ZIO-201 Preclinical Kidney Toxicity Data at Bone … - Feb 21, 2006 Cyclophosphamide and ifosfamide are widely used anti-cancer pro-drugs that have to be ... These effects are caused by metabolites of cyclophosphamide and ... RedOrbit … perivascular inflammation to cyclophosphamide therapy in MRL/MpJ- - Sep 1, 2007 Responses of pulmonary perivascular infiltrates to immunosuppressive therapy with cyclophosphamide (CY) were evaluated in the MRL/MpJ- lpr/lpr (MRL/1) mouse ... Am J Pathology (subscription) … -Capecitabine VersusDocetaxel-Doxorubicin-Cyclophosphamide: … - Mar 13, 2008 ...disease relapsed in 49.1% of the patients who did not have a clinical response to four cycles of doxorubicin and cyclophosphamide during the 78-month ... Medscape High-Dose Cyclophosphamide and Stem Cell Transplantation for … - Feb 1, 2006 Systemic lupus erythematosus is a devastating systemic autoimmune disease that predominantly affects young women, is more common in African-Americans than ... Journal of American Medical Association - Journal of American Medical Association... Etanercept Does Not Help Wegener's Disease - Jan 26, 2005 Repeated use of medications such as prednisone, cyclophosphamide and methotrexate also lead to problems and each relapse has the potential to cause patients ... RedOrbit Hepatotoxicity after low-dose cyclophosphamide therapy.(Letter to the... - Dec 1, 2006 Hepatotoxicity after low-dose cyclophosphamide therapy.(Letter to the editor) ... find Southern Medical Journal articles. To the Editor: Hepatotoxicity ... Pay-Per-View - Southern Medical Journal - HighBeam Research … Collaborators Present Combination Reovirus and Cyclophosphamide - Mar 19, 2007 The investigators concluded that the addition of cyclophosphamide may lead to improved efficacy of REOLYSIN(R) treatment. "Our ongoing clinical trials are ... Pay-Per-View - PR Newswire - HighBeam Research Drug Development; Novel class of cyclophosphamide prodrug developed - Sep 5, 2006 ..."A novel class of cyclophosphamide spiropiperaziniums was synthesized and evaluated for their in vivo anti-cancer activities against S-180 and H-22," ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Nonanthracycline TC Adjuvant Chemo Superior for Operable Breast … - Dec 13, 2005 13, 2005 (San Antonio) — Results from a trial that compared nonanthracycline adjuvant docetaxel/cyclophosphamide (TC) to standard ... Medscape TWO TYPES OF BREAST CANCER TREATMENTS SHOW BENEFIT - Dec 12, 2005 All of the women were first treated with doxorubicin and cyclophosphamide, a standard treatment protocol referred to as AC (representing the drugs ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones Newer Chemotherapies Improve Outcomes For Some Types Of Breast … - Apr 14, 2006 The trials compared (1): three regimens of cyclophosphamide, doxorubicin, and fluorouracil (January 1985 to April 1991); (2) three doses of doxorubicin ... Medical News Today - Medical News Today (press release) High-dose Chemotherapy Plus Growth Factor Helps in Locally Advanced … - Dec 2, 2005 The high-dose regimen (201 patients) consisted of two cycles of epirubicin and cyclophosphamide followed by tandem epirubicin and cyclophosphamide plus ... MedPage Today Taxane Plus Trastuzumab Better for the Heart Than Anthracycline … - Dec 19, 2006 The preferred treatment of choice is Herceptin in combination with a non-anthracycline-containing regimen such as cyclophosphamide and/or docetaxel," he ... DG News NICE approves free access to breast cancer drug - Sep 27, 2006 A combination therapy called TAC was approved in the regulator's final guidance; it combines Taxotere, cyclophosphamide and doxorubici, and will shortly be ... Hays Pharma Newer Chemotherapies Improve Outcomes for Some Types of Breast … - Apr 6, 2006 The trials compared (1): three regimens of cyclophosphamide, doxorubicin, and fluorouracil (January 1985 to April 1991); (2) three doses of doxorubicin ... newswise.com Hepatoblastoma; Single-agent cyclophosphamide ineffectual in refractor... - Jan 25, 2005 2005 JAN 25 - (NewsRx.com & NewsRx.net) -- Researchers from France reported that single-agent cyclophosphamide was not effective in refractory, relapsing HB ... Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones Hepatoblastoma; Single-agent cyclophosphamide ineffectual in refractor... - Jan 24, 2005 2005 JAN 24 - (NewsRx.com & NewsRx.net) -- Researchers from France reported that single-agent cyclophosphamide was not effective in refractory, relapsing HB ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones Brand Names/Synonyms: Cyclophosphamide is also known by the following brand names and/or synonymsASTA; Asta B 518; B 518; CB 4564; CB-4564; CP; CPA; CTX; CY; Clafen; Claphene; Cyclophosphamid; Cyclophosphamide; Cyclophosphamide Monohydrate; Cyclophosphamide Sterile; Cyclophosphamidum; Cyclophosphan; Cyclophosphane; Cyclophosphoramide; Cyclostin; Cyklofosfamid; Cytophosphan; Cytoxan; Cytoxan Lyoph; Endoxan; Endoxan R; Endoxan-Asta; Endoxana; Endoxanal; Endoxane; Enduxan; Genoxal; Hexadrin; Lyophilized Cytoxan; Mitoxan; Neosar; Procytox; Rcra Waste Number U058; Semdoxan; Sendoxan; Senduxan; Zyklophosphamid Drug Category: Cyclophosphamide is categorized under the following by the FDA: Antineoplastic Agents; Antirheumatic Agents; Immunosuppressive Agents; ATC:L01AA01 Dosage Forms: oral tablets, oral liquid, parenteral solution Absorption: 90-100% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2u{5}-phosphacyclohexan-2-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |